Voxel Valuation
Is VOX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of VOX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: VOX (PLN93.8) is trading below our estimate of fair value (PLN157.4)
Significantly Below Fair Value: VOX is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VOX?
Other financial metrics that can be useful for relative valuation.
What is VOX's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | zł985.14m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.3x |
Enterprise Value/EBITDA | 9.3x |
PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does VOX's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 30.7x | ||
EMC EMC Instytut Medyczny | 39.7x | n/a | zł474.7m |
NEU NEUCA | 31x | 25.7% | zł3.9b |
SNT Synektik Spólka Akcyjna | 19x | 4.3% | zł1.3b |
VMD Viemed Healthcare | 33x | 49.4% | CA$311.8m |
VOX Voxel | 15.4x | 12.2% | zł985.1m |
Price-To-Earnings vs Peers: VOX is good value based on its Price-To-Earnings Ratio (15.4x) compared to the peer average (30.7x).
Price to Earnings Ratio vs Industry
How does VOX's PE Ratio compare vs other companies in the European Healthcare Industry?
Price-To-Earnings vs Industry: VOX is good value based on its Price-To-Earnings Ratio (15.4x) compared to the European Healthcare industry average (18x).
Price to Earnings Ratio vs Fair Ratio
What is VOX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 15.4x |
Fair PE Ratio | 16.4x |
Price-To-Earnings vs Fair Ratio: VOX is good value based on its Price-To-Earnings Ratio (15.4x) compared to the estimated Fair Price-To-Earnings Ratio (16.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | zł93.80 | zł79.00 -15.8% | 24.1% | zł98.00 | zł60.00 | n/a | 2 |
Mar ’25 | zł93.60 | zł79.00 -15.6% | 24.1% | zł98.00 | zł60.00 | n/a | 2 |
Feb ’25 | zł82.20 | zł66.90 -18.6% | 10.3% | zł73.80 | zł60.00 | n/a | 2 |
Jan ’25 | zł78.60 | zł66.90 -14.9% | 10.3% | zł73.80 | zł60.00 | n/a | 2 |
Dec ’24 | zł72.00 | zł66.90 -7.1% | 10.3% | zł73.80 | zł60.00 | n/a | 2 |
Nov ’24 | zł59.20 | zł66.90 +13.0% | 10.3% | zł73.80 | zł60.00 | n/a | 2 |
Oct ’24 | zł54.20 | zł66.90 +23.4% | 10.3% | zł73.80 | zł60.00 | n/a | 2 |
Sep ’24 | zł58.00 | zł66.90 +15.3% | 10.3% | zł73.80 | zł60.00 | n/a | 2 |
Analyst Forecast: Target price is lower than the current share price.